Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

Pharmacodynamic comparison of low-dose ticagrelor to low-dose prasugrel in patients with prior myocardial infarction: the ALTIC-2 study.

Alexopoulos D, Sfantou D, Lianos I, Pappas C, Revela I, Triantafyllidi H, Ikonomidis I.

Platelets. 2019 Oct 13:1-3. doi: 10.1080/09537104.2019.1678123. [Epub ahead of print]

PMID:
31608799
2.

Temporal changes of noninvasive electrocardiographic risk factors for sudden cardiac death in post-myocardial infarction patients with preserved ejection fraction: Insights from the PRESERVE-EF study.

Xenogiannis I, Gatzoulis KA, Flevari P, Ikonomidis I, Iliodromitis E, Trachanas K, Vlachos K, Arsenos P, Tsiachris D, Tousoulis D, Brilakis ES, Alexopoulos D.

Ann Noninvasive Electrocardiol. 2019 Oct 12:e12701. doi: 10.1111/anec.12701. [Epub ahead of print]

PMID:
31605453
3.

Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries.

Peyracchia M, Saglietto A, Biolè C, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solé A, Liebetrau C, Manzano-Fernández S, Boccuzzi G, Henriques JPS, Wilton SB, Velicki L, Xanthopoulou I, Correia L, Rognoni A, Fabrizio U, Nuñez-Gil I, Montabone A, Taha S, Fujii T, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Kawaji T, Blanco PF, Garay A, Quadri G, Queija BC, Huczek Z, Paz RC, González-Juanatey JR, Fernández MC, Nie SP, D'Amico M, Pousa IM, Kawashiri MA, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Lopez-Cuenca A, Cequier A, Alexopoulos D, Iñiguez-Romo A, Grossomarra W, Usmiani T, Rinaldi M, D'Ascenzo F.

Am J Cardiovasc Drugs. 2019 Oct 5. doi: 10.1007/s40256-019-00373-1. [Epub ahead of print]

PMID:
31586336
4.

P2Y12 inhibitors for the treatment of acute coronary syndrome patients undergoing percutaneous coronary intervention: current understanding and outcomes.

Alexopoulos D, Varlamos C, Mpahara A, Lianos I.

Expert Rev Cardiovasc Ther. 2019 Oct 14:1-11. doi: 10.1080/14779072.2019.1675513. [Epub ahead of print]

PMID:
31583920
5.

P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects.

Filippo O, D'Ascenzo F, Raposeiras-Roubin S, Abu-Assi E, Peyracchia M, Bocchino PP, Kinnaird T, Ariza-Solé A, Liebetrau C, Manzano-Fernández S, Boccuzzi G, Henriques JPS, Templin C, Wilton SB, Omedè P, Velicki L, Xanthopoulou I, Correia L, Cerrato E, Rognoni A, Fabrizio U, Nuñez-Gil I, Iannaccone M, Montabone A, Taha S, Fujii T, Durante A, Song X, Gili S, Magnani G, Varbella F, Kawaji T, Blanco PF, Garay A, Quadri G, Alexopoulos D, Queija BC, Huczek Z, Paz RC, González Juanatey JR, Fernández MC, Nie SP, Pousa IM, Kawashiri MA, Gallo D, Morbiducci U, Conrotto F, Montefusco A, Dominguez-Rodriguez A, López-Cuenca A, Cequier A, Iñiguez-Romo A, Usmiani T, Rinaldi M, De Ferrari GM.

Eur Heart J Cardiovasc Pharmacother. 2019 Sep 12. pii: pvz048. doi: 10.1093/ehjcvp/pvz048. [Epub ahead of print]

PMID:
31511896
6.

Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients.

Lewis JP, Backman JD, Reny JL, Bergmeijer TO, Mitchell BD, Ritchie MD, Déry JP, Pakyz RE, Gong L, Ryan K, Kim EY, Aradi D, Fernandez-Cadenas I, Lee MTM, Whaley RM, Montaner J, Gensini GF, Cleator JH, Chang K, Holmvang L, Hochholzer W, Roden DM, Winter S, Altman R, Alexopoulos D, Kim HS, Gawaz M, Bliden K, Valgimigli M, Marcucci R, Campo G, Schaeffeler E, Dridi NP, Wen MS, Shin JG, Fontana P, Giusti B, Geisler T, Kubo M, Trenk D, Siller-Matula JM, Ten Berg JM, Gurbel PA, Schwab M, Klein TE, Shuldiner AR.

Eur Heart J Cardiovasc Pharmacother. 2019 Sep 3. pii: pvz045. doi: 10.1093/ehjcvp/pvz045. [Epub ahead of print]

PMID:
31504375
7.

Maternal pomegranate juice intake and brain structure and function in infants with intrauterine growth restriction: A randomized controlled pilot study.

Matthews LG, Smyser CD, Cherkerzian S, Alexopoulos D, Kenley J, Tuuli MG, Nelson DM, Inder TE.

PLoS One. 2019 Aug 21;14(8):e0219596. doi: 10.1371/journal.pone.0219596. eCollection 2019.

8.

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.

Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, So DYF, Stone GW, Storey RF, Tantry U, Trenk D, Valgimigli M, Waksman R, Angiolillo DJ.

JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537. doi: 10.1016/j.jcin.2019.03.034. Epub 2019 Jun 12. Review.

PMID:
31202949
9.

Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry.

De Fillippo O, Cortese M, D Ascenzo F, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Montefusco A, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Blanco PF, Garay A, Quadri G, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Rinaldi M.

Am J Cardiovasc Drugs. 2019 Aug;19(4):429. doi: 10.1007/s40256-019-00351-7.

PMID:
31106384
10.

Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction.

Raposeiras-Roubín S, Abu-Assi E, Cespón-Fernández M, Ibáñez B, García-Ruiz JM, D'Ascenzo F, Simao Henriques JP, Saucedo J, Caneiro-Queija B, Cobas-Paz R, Muñoz-Pousa I, Wilton SB, González Juanatey JR, Kikkert WJ, Núñez-Gil I, Ariza-Solé A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Gaita F, Huczek Z, Nie SP, Yan Y, Fujii T, Correia L, Kawashiri MA, Kedev S, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Kowara M, Filipiak K, Wang X, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Íñiguez-Romo A.

Rev Esp Cardiol (Engl Ed). 2019 May 17. pii: S1885-5857(19)30054-4. doi: 10.1016/j.rec.2019.02.012. [Epub ahead of print] English, Spanish.

PMID:
31105064
11.

Loading with Oral P2Y12 Receptor Inhibitors: To Crush or Not to Crush?

Alexopoulos D, Dragasis S, Kafkas N.

Thromb Haemost. 2019 Jul;119(7):1037-1047. doi: 10.1055/s-0039-1688790. Epub 2019 May 12.

PMID:
31079416
12.

Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention.

Raposeiras-Roubín S, Abu-Assi E, Caneiro Queija B, Cobas Paz R, D'Ascenzo F, Henriques JPS, Saucedo J, González-Juanatey J, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, Cespón Fernández M, Muñoz-Pousa I, López Rodríguez E, Castiñeira-Busto M, Barreiro Pardal C, García-Acuña JM, Southern D, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Gaita F, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kedev S, Íñiguez-Romo A.

Eur Heart J Acute Cardiovasc Care. 2019 May 1:2048872619827471. doi: 10.1177/2048872619827471. [Epub ahead of print]

PMID:
31042052
13.

Recurrent atherosclerosis complications as a mechanism for stent failure.

Andreou I, Stone PH, Ikonomidis I, Alexopoulos D, Sabaté M.

Hellenic J Cardiol. 2019 Apr 26. pii: S1109-9666(19)30121-6. doi: 10.1016/j.hjc.2019.04.007. [Epub ahead of print] Review.

14.

Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry.

De Filippo O, Cortese M, D Ascenzo F, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Montefusco A, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Blanco PF, Garay A, Quadri G, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Rinaldi M.

Am J Cardiovasc Drugs. 2019 Aug;19(4):381-391. doi: 10.1007/s40256-019-00339-3. Erratum in: Am J Cardiovasc Drugs. 2019 May 20;:.

PMID:
31030413
15.

Impaired hippocampal development and outcomes in very preterm infants with perinatal brain injury.

Strahle JM, Triplett RL, Alexopoulos D, Smyser TA, Rogers CE, Limbrick DD Jr, Smyser CD.

Neuroimage Clin. 2019;22:101787. doi: 10.1016/j.nicl.2019.101787. Epub 2019 Mar 18.

16.

Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.

D'Ascenzo F, Bertaina M, Fioravanti F, Bongiovanni F, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Blanco PF, Garay A, Quadri G, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Rinaldi M, Lüscher TF.

Eur J Prev Cardiol. 2019 Mar 12:2047487319836327. doi: 10.1177/2047487319836327. [Epub ahead of print]

PMID:
30862233
17.

Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function.

Ikonomidis I, Pavlidis G, Katsimbri P, Andreadou I, Triantafyllidi H, Tsoumani M, Varoudi M, Vlastos D, Makavos G, Kostelli G, Βenas D, Lekakis J, Parissis J, Boumpas D, Alexopoulos D, Iliodromitis E.

Clin Res Cardiol. 2019 Oct;108(10):1093-1101. doi: 10.1007/s00392-019-01443-9. Epub 2019 Mar 11.

PMID:
30859382
18.

Antithrombotic treatment in atrial fibrillation patients undergoing PCI: Is dual therapy the winner?

Mantis C, Alexopoulos D.

Thromb Res. 2019 Apr;176:133-139. doi: 10.1016/j.thromres.2019.02.022. Epub 2019 Feb 22.

PMID:
30826397
19.

De-Escalation of Treatment With Oral P2Y12 Receptor Inhibitors: Current Status and Perspectives.

Alexopoulos D, Lianos I, Vlachakis P, Sfantou D, Dragona VM, Varlamos C.

J Cardiovasc Pharmacol Ther. 2019 Jul;24(4):304-314. doi: 10.1177/1074248418823724. Epub 2019 Feb 5.

PMID:
30722685
20.

Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study.

Kubica J, Adamski P, Buszko K, Barańska M, Sikora J, Marszałł MP, Sobczak P, Sikora A, Kuliczkowski W, Fabiszak T, Kubica A, Jilma B, Alexopoulos D, Navarese EP.

Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):139-148. doi: 10.1093/ehjcvp/pvz004.

PMID:
30689800
21.

Increase in Carotid Temperature Heterogeneity Is Associated With Cardiovascular and Cerebrovascular Events.

Toutouzas K, Benetos G, Oikonomou G, Barampoutis N, Koutagiar I, Galanakos S, Karmpalioti M, Drakopoulou M, Stathogiannis K, Bounas P, Gata V, Antoniadou F, Davlouros P, Alexopoulos D, Hahalis G, Siores E, Sfikakis PP, Tousoulis D.

Circ Cardiovasc Imaging. 2018 Nov;11(11):e008292. doi: 10.1161/CIRCIMAGING.118.008292. No abstract available.

PMID:
30571323
22.

Prenatal to postnatal trajectory of brain growth in complex congenital heart disease.

Ortinau CM, Mangin-Heimos K, Moen J, Alexopoulos D, Inder TE, Gholipour A, Shimony JS, Eghtesady P, Schlaggar BL, Smyser CD.

Neuroimage Clin. 2018;20:913-922. doi: 10.1016/j.nicl.2018.09.029. Epub 2018 Sep 27.

23.

Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI.

Conrotto F, Bertaina M, Raposeiras-Roubin S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Quadri G, Varbella F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Abu-Assi E, D'Ascenzo F.

Eur Heart J Acute Cardiovasc Care. 2018 Oct 1:2048872618802783. doi: 10.1177/2048872618802783. [Epub ahead of print]

PMID:
30270638
24.

Cangrelor in Ticagrelor-Loaded STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.

Alexopoulos D, Pappas C, Sfantou D, Xanthopoulou I, Didagelos M, Kikas P, Ziakas A, Tziakas D, Karvounis H, Iliodromitis E.

J Am Coll Cardiol. 2018 Oct 2;72(14):1750-1751. doi: 10.1016/j.jacc.2018.07.041. No abstract available.

25.

Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry.

D'Ascenzo F, Grosso A, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Ali HH, Magnani G, Autelli M, Blanco PF, Garay A, Quadri G, Marra WG, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Raposeiras-Roubin S.

Int J Cardiol. 2018 Dec 15;273:29-33. doi: 10.1016/j.ijcard.2018.09.020. Epub 2018 Sep 6.

PMID:
30228021
26.

In-Scaffold Neoatherosclerosis: An Overestimated Entity?

Andreou I, Alexopoulos D.

J Am Coll Cardiol. 2018 Aug 28;72(9):1063-1064. doi: 10.1016/j.jacc.2018.05.069. No abstract available.

27.

CYP2C19 Genetic Polymorphism and Pharmacodynamics of Prasugrel Maintenance Dose in Patients Undergoing Percutaneous Coronary Intervention.

Kassimis G, Alexopoulos D.

Cardiology. 2018;140(4):237-238. doi: 10.1159/000492422. Epub 2018 Aug 23. No abstract available.

28.

Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study.

Grodecki K, Huczek Z, Scisło P, Kowara M, Raposeiras-Roubín S, D'Ascenzo F, Abu-Assi E, Henriques JPS, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song XT, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Nie SP, Fujii T, Correia L, Kawashiri MA, García-Acuña JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Scarano S, Gaita F, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Opolski G, Filipiak KJ.

Thromb Res. 2018 Aug;168:156-163. doi: 10.1016/j.thromres.2018.06.022. Epub 2018 Jun 28.

PMID:
30064688
29.

Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome.

Raposeiras-Roubín S, Caneiro Queija B, D'Ascenzo F, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tomassini F, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Calvo-Iglesias F, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A, Abu-Assi E.

Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):215-223. doi: 10.1016/j.rec.2018.06.004. Epub 2018 Jul 18. English, Spanish.

PMID:
30029980
30.

Does Ticagrelor Improve Endothelial Function?

Moulias A, Xanthopoulou I, Alexopoulos D.

J Cardiovasc Pharmacol Ther. 2019 Jan;24(1):11-17. doi: 10.1177/1074248418786936. Epub 2018 Jul 10.

PMID:
29991269
31.

Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel.

Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Fernández-Barbeira S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tommassini F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A.

Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):298-304. doi: 10.1016/j.rec.2018.05.021. Epub 2018 Jun 25. English, Spanish.

PMID:
29954720
32.

Aspirin Hypersensitivity in Patients Undergoing Percutaneous Coronary Intervention. What Should We be Doing?

Kassimis G, Raina T, Alexopoulos D.

Curr Vasc Pharmacol. 2019;17(4):326-331. doi: 10.2174/1570161116666180604100220.

PMID:
29866010
33.

Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention.

Alexopoulos D, Xenogiannis I, Vlachakis P, Tantry U, Gurbel PA.

Thromb Haemost. 2018 Jul;118(7):1131-1140. doi: 10.1055/s-0038-1649484. Epub 2018 Jun 4. Review.

PMID:
29864784
34.

Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry.

Guerrero C, Garay A, Ariza-Solé A, Formiga F, Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Kinnaird T, Manzano-Fernández S, Alegre O, Sánchez-Salado JC, Lorente V, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Conrotto F, Bertaina M, Autelli M, Grosso A, Blanco PF, Quadri G, Varbella F, Tomassini F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Alexopoulos D, Iñiguez-Romo A, Gaita F, Cequier Á.

Thromb Res. 2018 Jul;167:142-148. doi: 10.1016/j.thromres.2018.05.024. Epub 2018 May 22.

PMID:
29857270
35.

Ticagrelor Versus Clopidogrel as Part of Dual or Triple Antithrombotic Therapy: a Systematic Review and Meta-Analysis.

Andreou I, Briasoulis A, Pappas C, Ikonomidis I, Alexopoulos D.

Cardiovasc Drugs Ther. 2018 Jun;32(3):287-294. doi: 10.1007/s10557-018-6795-9.

PMID:
29766335
36.

Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry.

D'Ascenzo F, Celentani D, Brustio A, Grosso A, Raposeiras-Roubín S, Abu-Assi E, Henriques JPS, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, García-Acuña JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Moretti C, D'Amico M, Gaita F.

Am J Cardiovasc Drugs. 2018 Aug;18(4):299-309. doi: 10.1007/s40256-018-0273-4.

PMID:
29691803
37.

Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.

Xanthopoulou I, Dragona VM, Davlouros P, Tsioufis C, Iliodromitis E, Alexopoulos D; GRAPE-AF Investigators.

Cardiovasc Drugs Ther. 2018 Apr;32(2):191-196. doi: 10.1007/s10557-018-6789-7.

PMID:
29679301
38.

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).

Bergmeijer TO, Reny JL, Pakyz RE, Gong L, Lewis JP, Kim EY, Aradi D, Fernandez-Cadenas I, Horenstein RB, Lee MTM, Whaley RM, Montaner J, Gensini GF, Cleator JH, Chang K, Holmvang L, Hochholzer W, Roden DM, Winter S, Altman RB, Alexopoulos D, Kim HS, Déry JP, Gawaz M, Bliden K, Valgimigli M, Marcucci R, Campo G, Schaeffeler E, Dridi NP, Wen MS, Shin JG, Simon T, Fontana P, Giusti B, Geisler T, Kubo M, Trenk D, Siller-Matula JM, Ten Berg JM, Gurbel PA, Hulot JS, Mitchell BD, Schwab M, Ritchie MD, Klein TE, Shuldiner AR; ICPC Investigators.

Am Heart J. 2018 Apr;198:152-159. doi: 10.1016/j.ahj.2017.12.010. Epub 2017 Dec 17. Review.

39.

Early P2Y12 Inhibitors Escalation in Primary PCI Patients: Insights from the RENOVAMI Registry.

Lupi A, Bona RD, Meliga E, Capodanno D, Schaffer A, Bongo AS, Gaudio G, Guasti L, Alexopoulos D, Valgimigli M, Porto I.

Thromb Haemost. 2018 May;118(5):852-863. doi: 10.1055/s-0038-1635578. Epub 2018 Apr 4.

PMID:
29618159
40.

Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry.

Garay A, Ariza-Solé A, Formiga F, Raposeiras-Roubín S, Abu-Assi E, Sánchez-Salado JC, Lorente V, Alegre O, Henriques JPS, D'Ascenzo F, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, García-Acuña JM, Southern D, Alfonso E, Terol B, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Gaita F, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Cequier A.

Thromb Haemost. 2018 May;118(5):929-938. doi: 10.1055/s-0038-1635259. Epub 2018 Apr 3.

PMID:
29614517
41.

Effects of an artificial placenta on brain development and injury in premature lambs.

Church JT, Werner NL, Coughlin MA, Menzel-Smith J, Najjar M, Carr BD, Parmar H, Neil J, Alexopoulos D, Perez-Torres C, Ge X, Beeman SC, Garbow JR, Mychaliska GB.

J Pediatr Surg. 2018 Jun;53(6):1234-1239. doi: 10.1016/j.jpedsurg.2018.02.091. Epub 2018 Mar 8.

42.

Dynamic patterns of cortical expansion during folding of the preterm human brain.

Garcia KE, Robinson EC, Alexopoulos D, Dierker DL, Glasser MF, Coalson TS, Ortinau CM, Rueckert D, Taber LA, Van Essen DC, Rogers CE, Smyser CD, Bayly PV.

Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):3156-3161. doi: 10.1073/pnas.1715451115. Epub 2018 Mar 5.

43.

Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score.

Raposeiras-Roubín S, Faxén J, Íñiguez-Romo A, Henriques JPS, D'Ascenzo F, Saucedo J, Szummer K, Jernberg T, James SK, Juanatey JRG, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, Caneiro-Queija B, Cobas-Paz R, Acuña JMG, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Gaita F, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Rivera-Asenjo D, Abu-Assi E.

Int J Cardiol. 2018 Mar 1;254:10-15. doi: 10.1016/j.ijcard.2017.10.103. Epub 2018 Jan 28.

PMID:
29407077
44.

Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice.

Yan Y, Wang X, Fan JY, Nie SP, Raposeiras-Roubín S, Abu-Assi E, Simao Henriques JP, D'Ascenzo F, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song XT, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Fujii T, Correia LC, Kawashiri MA, Kedev S.

J Geriatr Cardiol. 2017 Nov;14(11):679-687. doi: 10.11909/j.issn.1671-5411.2017.11.003.

45.

Absence of differential effect of ticagrelor versus prasugrel maintenance dose on endothelial function in patients with stable coronary artery disease.

Xanthopoulou I, Bei I, Bampouri T, Barampoutis N, Moulias A, Davlouros P, Alexopoulos D.

Hellenic J Cardiol. 2018 Nov - Dec;59(6):338-343. doi: 10.1016/j.hjc.2017.12.008. Epub 2017 Dec 29.

46.

Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives.

Alexopoulos D, Pappas C, Sfantou D, Lekakis J.

J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):13-22. doi: 10.1177/1074248417715004. Epub 2017 Jun 15. Review.

PMID:
29228817
47.

International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies.

Angiolillo DJ, Rollini F, Storey RF, Bhatt DL, James S, Schneider DJ, Sibbing D, So DYF, Trenk D, Alexopoulos D, Gurbel PA, Hochholzer W, De Luca L, Bonello L, Aradi D, Cuisset T, Tantry US, Wang TY, Valgimigli M, Waksman R, Mehran R, Montalescot G, Franchi F, Price MJ.

Circulation. 2017 Nov 14;136(20):1955-1975. doi: 10.1161/CIRCULATIONAHA.117.031164. Epub 2017 Oct 30. Review.

PMID:
29084738
48.

Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study.

Kubica J, Adamski P, Buszko K, Kubica A, Kuliczkowski W, Fabiszak T, Jilma B, Alexopoulos D, Paciorek P, Navarese EP.

Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):152-157. doi: 10.1093/ehjcvp/pvx032.

PMID:
29040445
49.

Low-Dose Ticagrelor Versus Clopidogrel in Patients With Prior Myocardial Infarction.

Alexopoulos D, Despotopoulos S, Xanthopoulou I, Davlouros P.

J Am Coll Cardiol. 2017 Oct 17;70(16):2091-2092. doi: 10.1016/j.jacc.2017.08.031. No abstract available.

50.

Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?

Alexopoulos D, Katogiannis K, Sfantou D, Lekakis J.

Platelets. 2018 May;29(3):228-237. doi: 10.1080/09537104.2017.1353685. Epub 2017 Oct 12. Review.

PMID:
29022423

Supplemental Content

Loading ...
Support Center